Bacillus subtilis ATCC 21332
Bacillus subtilis ATCC 21332 is a strain studied primarily for its production of surfactin, a lipopeptide (fat-linked peptide) compound with antimicrobial and biosurfactant properties. In vitro and genetic studies have characterized the biosynthetic pathway for surfactin and explored iron supplementation as a strategy to enhance yields. This strain is a laboratory and industrial reference organism for surfactin research rather than a human probiotic candidate; no clinical or in vivo health benefit evidence is linked to this specific strain entry.
Research Study-type filters use AI-classified labels, audited but not guaranteed — check the paper itself before leaning on one. How we classify this →
13 papers reference this strain in the probiotic database.
Discussion
Be the first to comment.
Sign in to join the discussion.
Citations
Selected papers that name this strain.
-
[1]
Source →Modification of Bacillus subtilis ATCC 21332 and Study of Proteins Related to Surfactin ProductionBacillus subtilis ATCC 21332的改質與表面素生產相關蛋白質之研究· · 2006
-
[2]
PMID 15176908 →Optimizing Iron Supplement Strategies for Enhanced Surfactin Production with Bacillus subtilis· Biotechnology Progress · 2004
-
[3]
PMID 2848009 →Identification of a genetic locus required for biosynthesis of the lipopeptide antibiotic surfactin in Bacillus subtilis· Journal of Bacteriology · 1988